InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Discover the complete record of transactions filed by Clay Shaundra, 董事. Director active across 1 company, notably Integra Lifesciences Holdings CORP. Aggregated, 5 filings have been published. Activity tracked since 14 May 2021. The latest transaction was disclosed on 9 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Clay Shaundra
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报5 总计
19,592 股0Common StockSEC:0000917520-25-000047:0
8,696 股0Common StockSEC:0000917520-24-000070:0
4,486 股0Common StockSEC:0001209191-23-029808:0
1,265 股0Common StockSEC:0001209191-22-029720:0
64 股0Common StockSEC:0001209191-21-033135:0
5 条申报中的 5 条
About Clay Shaundra
Shaundra Clay serves as a Board Member at Integra Lifesciences Holdings Corp. She brings expertise in the medical devices and health sectors. As a board member, Shaundra plays a key role in the strategic direction of the company, ensuring regulatory compliance and innovation. Her experience is valuable in guiding strategic decisions.
